Cigna Group (NYSE:CI)

An analysis of the short-term activity ratios from 2020 to 2024 reveals a general deceleration in asset turnover paired with a strategic extension of payment terms, resulting in a strengthened cash position.

Inventory Management

Inventory turnover experienced a general decline from 32.70 in 2020 to a low of 23.70 in 2023, before recovering to 27.27 in 2024. This trend is mirrored in the average inventory processing period, which expanded from 11 days to a peak of 15 days in 2023, subsequently contracting to 13 days by the end of 2024.

Receivables Performance

A consistent downward trend is observed in the receivables turnover ratio, which fell from 19.47 in 2020 to 15.60 in 2024. Consequently, the average receivable collection period has lengthened steadily from 19 days to 23 days over the five-year period, indicating a slowing rate of cash collection from customers.

Payables Strategy

The payables turnover ratio decreased progressively from 7.75 in 2020 to 6.41 in 2024. This indicates a strategic shift toward extending the average payables payment period, which rose from 47 days to 57 days. This increase suggests a greater reliance on supplier credit to fund operations.

Operating and Cash Conversion Cycles

The operating cycle expanded from 30 days in 2020 to 36 days in 2024, driven by the slower turnover of receivables and inventory. However, the cash conversion cycle has remained negative throughout the period and has improved from -17 days to -21 days. The widening gap between the operating cycle and the payment period indicates that liabilities are being settled significantly slower than assets are being converted to cash, effectively providing the organization with a source of interest-free working capital.

The analysis of operating activity between 2020 and 2024 reveals a consistent expansion in both pharmacy and other service costs and the corresponding inventory levels. While both metrics increased throughout the period, the rate of growth differed, resulting in a fluctuating inventory turnover ratio that declined for three consecutive years before recovering in the final period.

Expenditure and Asset Growth

Pharmacy and other service costs exhibited a steady upward trajectory, rising from 103,484 million USD in 2020 to 182,509 million USD in 2024. The most significant acceleration occurred between 2023 and 2024, where costs increased by approximately 36%. Simultaneously, inventory levels grew every year, increasing from 3,165 million USD in 2020 to 6,692 million USD in 2024, representing more than a doubling of the inventory base over the five-year span.

Inventory Turnover Trends

The inventory turnover ratio experienced a sustained decline from 32.70 in 2020 to a low of 23.70 in 2023. This downward trend suggests that inventory accumulation grew at a faster proportional rate than the associated service costs during this window, indicating a reduction in the efficiency of inventory movement. However, this trend reversed in 2024, with the ratio climbing to 27.27.

Operational Efficiency Insights

The recovery in the turnover ratio in 2024 is primarily attributed to the sharp increase in pharmacy and other service costs, which outpaced the growth in inventory for that specific year. While the 2024 ratio remains below the 2020 and 2021 levels, the shift indicates an improvement in the velocity of inventory utilization relative to the volume of service costs incurred.

The analysis of short-term operating activity reveals a consistent decline in the efficiency of receivables collection over the five-year period ending December 31, 2024. While pharmacy revenues have expanded significantly, the growth in noninsurance customer receivables has occurred at a rate that has outpaced revenue gains, leading to a progressive reduction in the receivables turnover ratio.

Pharmacy Revenues

A sustained upward trajectory is observed, with revenues increasing from 107,769 million US dollars in 2020 to 185,362 million US dollars in 2024. The most pronounced growth occurred between 2023 and 2024, where revenues rose by approximately 35%.

Noninsurance Customer Receivables

Outstanding receivables have grown steadily every year, rising from 5,534 million US dollars in 2020 to 11,879 million US dollars in 2024. The total balance of receivables more than doubled over the analyzed period, reflecting an increase in the volume of credit extended to customers.

Receivables Turnover

The turnover ratio exhibits a continuous downward trend, falling from 19.47 in 2020 to 15.60 in 2024. This decline indicates a slowing velocity in the conversion of receivables into cash, suggesting a lengthening of the average collection period for noninsurance customers.

The divergence between the accelerating growth of revenues and the deteriorating turnover ratio suggests a shift in credit terms or a decrease in the promptness of customer payments. This trend indicates that while the scale of operations is increasing, the efficiency of the working capital cycle regarding noninsurance receivables is weakening.

An analysis of operational activity indicates a steady expansion in both pharmacy and other service costs and their corresponding payables from 2020 through 2024. The most pronounced increase occurred between 2023 and 2024, where costs rose from 133,801 million to 182,509 million, and payables increased from 19,815 million to 28,465 million.

Payables Turnover Trend

A consistent downward trend is observed in the payables turnover ratio, which declined from 7.75 in 2020 to 6.41 in 2024. This gradual decrease indicates a slowing rate of payment to pharmacy and service providers over the five-year period.

Working Capital Dynamics

The decline in the turnover ratio suggests an extension of the average payment period. While total service costs increased by approximately 76% between 2020 and 2024, the associated payables grew by approximately 113%. This disproportionate growth in liabilities relative to costs has contributed to the reduction in the turnover ratio, which effectively allows for the retention of cash for longer periods.

Recent Operational Shift

The most significant shift in the operational cycle occurred in the final year of the period. The sharp rise in both total service costs and the outstanding payable balance in 2024 further accelerated the decline of the turnover ratio to its lowest point in the analyzed timeframe, signaling a strategic or operational shift in how obligations to providers are managed.

The analysis of short-term operating activity reveals a persistent state of negative working capital coupled with a strong and accelerating growth trend in pharmacy revenues over the five-year period ending December 31, 2024.

Pharmacy Revenue Trends

A consistent upward trajectory is observed in pharmacy revenues, which increased from US$ 107,769 million in 2020 to US$ 185,362 million in 2024. While growth was steady between 2020 and 2023, a significant acceleration occurred in 2024, where revenues rose by approximately 35% compared to the previous year.

Working Capital Position

Working capital remained negative throughout the entire period, indicating that current liabilities consistently exceeded current assets. The deficit fluctuated, narrowing slightly in 2021 to US$ -7,438 million before expanding to a peak deficit of US$ -11,365 million in 2023. By the end of 2024, the negative position improved to US$ -9,109 million.

Working Capital Turnover Analysis

The working capital turnover ratio remained negative due to the structural deficit in working capital. Between 2020 and 2023, the ratio fluctuated within a range of -11.57 to -16.32. In 2024, the ratio shifted significantly to -20.35. This movement indicates that revenue generation increased at a pace that far exceeded the growth of the working capital deficit, suggesting a higher volume of revenue supported by the existing current liability structure.

The analysis of short-term operating activity indicates a period of declining inventory efficiency between 2020 and 2023, followed by a partial recovery in 2024.

Inventory Turnover

A consistent downward trend was observed from 2020 to 2023, with the ratio decreasing from 32.70 to 23.70. This decline suggests a slowing rate of inventory replacement over that four-year span. However, the trend reversed in 2024, as the turnover ratio increased to 27.27, indicating an improvement in the velocity of inventory movement compared to the prior year.

Average Inventory Processing Period

The duration required to process inventory increased steadily from 11 days in 2020 to a peak of 15 days in 2023. This expansion of the processing cycle aligns with the decline in turnover ratios, reflecting a longer hold time for inventory. In 2024, the processing period contracted to 13 days, signaling a return toward higher operational efficiency.

Operational Correlation

An inverse correlation is evident between the turnover ratio and the processing period. The period of peak inefficiency occurred in 2023, characterized by the lowest turnover and the longest processing time. The subsequent improvement in 2024 suggests a correction in inventory management or a change in demand patterns that reduced the time required to clear inventory.

An analysis of short-term operating activity reveals a gradual decline in the efficiency of receivable collections over the period from 2020 to 2024. There is a clear inverse correlation between the turnover ratio and the collection period, indicating a steady extension of the cash conversion cycle.

Receivables Turnover Performance

The receivables turnover ratio decreased consistently from 19.47 in 2020 to 15.60 in 2024. This downward trajectory suggests that the company is generating fewer turnovers of its receivables per year, implying a reduction in the velocity of credit recovery.

Average Collection Period Expansion

The average receivable collection period rose from 19 days in 2020 and 2021 to 23 days by December 31, 2024. This increase reflects a slowing rate of payment receipt, which potentially impacts short-term liquidity and the management of working capital.

Trend Synthesis

The degradation in collection efficiency accelerated after 2021, with the collection period increasing every consecutive year through 2024. This pattern suggests a systemic shift in payment behaviors or adjustments in credit policies that have resulted in longer outstanding balances and reduced operating liquidity.

The overall operating cycle exhibits a gradual upward trajectory, extending from 30 days in 2020 to 36 days by the end of 2024. This expansion indicates a slow increase in the time required to convert operating inputs into cash, representing a overall lengthening of the working capital cycle.

Average Inventory Processing Period

This metric showed a moderate increase from 11 days in 2020 to a peak of 15 days in 2023, before contracting to 13 days in 2024. The movement suggests a period of expanding inventory holding times followed by a recent improvement in processing efficiency.

Average Receivable Collection Period

A consistent and linear increase is observed in the collection period, which rose from 19 days in 2020 to 23 days in 2024. This trend indicates a steady slowing in the pace of payment collections from customers over the five-year period.

Operating Cycle

The total operating cycle increased by 20% between 2020 and 2024. The growth was most pronounced between 2021 and 2023, after which the cycle plateaued at 36 days. The overall extension is driven primarily by the lengthening of the receivable collection period, offset slightly in the final year by a reduction in the inventory processing period.

An analysis of the operating activity ratios between 2020 and 2024 reveals a consistent trend toward the lengthening of the accounts payable cycle. There is a direct inverse correlation between the payables turnover ratio and the average payment period, indicating a systematic shift in how obligations to suppliers and creditors are managed.

Payables Turnover Trend

A steady decline in the payables turnover ratio is observed over the five-year period. The ratio decreased from 7.75 in 2020 to 6.41 by the end of 2024. This downward trajectory indicates that the company is cycling through its accounts payable less frequently, suggesting a reduction in the velocity of payments made to vendors.

Average Payables Payment Period Evolution

The average payables payment period exhibits a continuous upward trend, increasing from 47 days in 2020 to 57 days in 2024. The growth was gradual between 2020 and 2022, followed by a more pronounced acceleration between 2022 and 2024. This represents a total extension of the payment cycle by 10 days over the analyzed timeframe.

Working Capital and Liquidity Implications

The extension of the payment period suggests a strategic utilization of supplier credit to preserve cash flow. By delaying payments to creditors, the company effectively increases its available working capital and improves its short-term liquidity position. The consistency of this trend suggests a deliberate operational strategy to optimize the cash conversion cycle by maximizing the float on accounts payable.

The organization maintains a consistently negative cash conversion cycle over the period from 2020 to 2024, indicating a working capital model where cash is generated from sales and collections before payments to suppliers are required. This negative cycle suggests that the company effectively uses its suppliers as a source of short-term financing.

Average Inventory Processing Period

The inventory processing period remained relatively stable, with a slight upward trend from 11 days in 2020 to a peak of 15 days in 2023, followed by a decrease to 13 days in 2024. This suggests minimal volatility in the management of inventory turnover.

Average Receivable Collection Period

A gradual increase is observed in the time required to collect receivables, which rose from 19 days in 2020 to 23 days by the end of 2024. This trend indicates a slight deceleration in the speed of cash inflows from customers over the five-year span.

Average Payables Payment Period

The payables payment period demonstrates a consistent and steady increase, moving from 47 days in 2020 to 57 days in 2024. This represents a strategic extension of payment terms to vendors, which serves as the primary driver for the company's overall cash position.

Cash Conversion Cycle

The overall cash conversion cycle transitioned from -17 days in 2020 to -21 days in 2024. The increase in the payables payment period outweighed the marginal increases in both inventory processing and receivable collection times, resulting in a more favorable negative cycle and an enhanced short-term liquidity profile.